Efficacy analysis
SECONDARY, INTERACTION
The month-specific changes in glycemic parameters of primary outcomes are shown in Fig. Treatment effect of sitagliptin on glycemic parameters. Changes in fasting plasma glucose (FPG, mg/dL) (Average changes in parameters of primary and secondary outcomes during treatment based on a mixed-effects model analysis.*‘Difference’ indicates the average change in parameters of primary and secondary outcomes caused by a specific treatment. ‘Interaction’ occurs when the length of treatment affected the average change in a selected parameter. Among the secondary outcomes shown in Table 